Status:
COMPLETED
Casodex/Zoladex Biomarkers in Localised Prostate Cancer
Lead Sponsor:
Tampere University
Conditions:
Prostate Cancer
Eligibility:
MALE
18-70 years
Phase:
PHASE4
Brief Summary
To evaluate anti-androgen (bicalutamide) induced biological and molecular changes in prostate comparison to chemical castration induced (goserelin) ones
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Histologically confirmed localised prostate biopsy specimen that contains sufficient tumour for evaluation of cell proliferation and apoptosis markers
- Patients who are scheduled for radical prostatectomy with curative intents
Exclusion
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2006
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00293696
Start Date
October 1 2004
End Date
November 1 2006
Last Update
May 8 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TUCH
Tampere, Finland, 33521